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Abstract:	 Muscle weakness is a prominent feature of end-state renal failure. While the cause of this strongly disabling muscle 
condition is at present unknown, there are suggestions that metabolic factors may play a role in this type of muscle 
fatigue. In vitro measurements of muscle function of the fast-twitch extensor digitorum longus (EDL) muscle of adult rats 
was performed. Isolated muscles were exposed to either a normal ionic environment, a uremic environment – with 
and without alpha-ketoglutarate (AKG), or with and without succinate, before being field stimulated until they were 
almost totally fatigued. The addition of AKG to the uremic environment was found to restore muscle performance 
so that the muscles no longer differed significantly from those incubated in a normal ionic environment. Similar 
effects to those noted for AKG were observed for succinate. It is concluded that AKG and succinate have a positive 
and restorative effect on muscle fatigue in uremic fast skeletal muscles in vitro. This beneficial form of treatment is 
proposed to act at the in vitro isolated muscle level by means of phosphate-binding, as the literature shows that an 
elevated plasma Pi concentration with renal failure disrupts normal muscle function. 
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ORIGINAL ARTICLE
et al. [6], reported that an effect of elevated Pi is a decrease in 
Ca2+-transport leading to a decrease in force over time. 
One way of decreasing Pi is to add alpha-ketoglutarate (AKG) 
to a muscle, since AKG acts as a phosphate binder. AKG, which 
is part of the Krebs cycle, is normally turned over at a very high 
rate. Indeed, a clinical crossover open trial study of 10 chronic 
hemodialysis patients concluded that calcium ketoglutarate 
may be an effective and safe, yet very costly alternative to 
treatment with aluminium-containing phosphate binders 
[7]. Over half a century ago, however, Mudge [8], showed in a 
study of potassium accumulation by rabbit kidney slices, that 
oxygen consumption per hour per mg wet weight of tissue 
increased by 209% cf. control levels upon addition of AKG, 
but increased by some 302% upon addition of succinate. With 
every completed TCA cycle, succinyl CoA is converted to 
succinate and a single Pi is converted to a high-energy bond 
e.g. ATP or GTP. Thus, if addition of TCA intermediates to a 
tissue causes an increase in metabolism which involves more 
frequent TCA cycling, one might anticipate a reduction in the 
level of Pi in a given medium. 
The aim of this study, therefore, was to test the hypothesis 
that the addition of succinate to a uremic environment has 
an equally beneficial effect on muscle performance to that of 
alpha-ketoglutarate addition. It is hoped that by testing this 
hypotheses, a cost effective way of improving muscle function 
in uremic patients may be achieved.
MATERIALS	AND	METHODS
Preparation of animals and muscle. Wistar Hannover 
rats housed at the animal facilities of The Faculty of Life 
Sciences, Copenhagen University were used. The animals 
INTRODUCTION
In a recent study [1], we confirmed earlier reports of muscle 
abnormalities reported in patients with end-state renal 
disease (ESRD; uremia) [2, 3]. Our studies showed a clear 
pattern of fatigue in fast muscles in uremic patients with 
direct measurements using surface EMG and in vitro studies 
of rat muscles incubated in a medium based closely on typical 
hemodialysis patient values.
Arguably, one of the main differences between the ionic 
environment of muscle in a uremic condition compared to 
the normal one is an elevated concentration of inorganic 
phosphate and urea [1]. The increase in concentration of urea 
will create a higher osmolarity, which in turn may have an 
effect on the propagation of action potentials. In metabolic 
terms, on the other hand, urea may be considered inert. This 
leaves the inorganic phosphate (Pi) as a more likely candidate, 
capable of affecting muscle function through changes in cell 
metabolism. An elevated concentration of plasma phosphate 
results in an elevated phosphate concentration inside the cell. 
Furthermore, phosphates are charged and thereby may affect 
the charge distribution at the cell membrane, apart from any 
osmotic effect created by an abundance of Pi in general. To 
date, it is known from studies with genetically modified mice 
(CK-/-), that fast-twitch skeletal muscles display an increased 
myoplasmic Pi concentration at rest, and show a markedly 
lower force than that of wild-type mice [4]. Moreover, the work 
of Millar and Homsher [5] shows that an increase in Pi creates 
a decreased sensitivity of myofilaments to Ca2+, whilst Fryer 
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were raised under identical conditions with a 12/12 light cycle, 
and had a body weight of 280-350 g. The rats were fed rodent 
pellets ad libitum (Altromin No.1314 Spezialfutterwerke, Lage, 
Germany) and given free access to drinking water. The rats 
were killed by exposure to 95% CO2 and cervical dislocation, 
in accordance with local and national guidelines. 
Extensor digitorum longus (EDL) muscles were dissected 
intact with both tendons attached. This lower hind-limb 
muscle has its origin in the distal portion of the femur and 
inserts upon the distal phalanx of digits 2-5. Muscles were 
securely attached at one end to the force transducer, and at 
the other to 2 metal pins on the mounting/stimulating block. 
As described in part [9, 10], isolated rat muscles were mounted 
vertically in thermostatically-controlled chambers, stimulated 
directly with supra-maximal pulses, and force development 
was recorded. No neuronal blockers were used in this study to 
avoid the risk of any side-effects of such compounds on muscle 
performance. The thermostatically-controlled chambers had 
an internal depth and diameter of 5.5 and 3.2 cm, respectively, 
holding 44 ml of incubation buffer. The mounting/stimulation 
block, made of perspex, was 8 cm long, 1.5 cm wide, and 1 cm 
thick. Into this perspex block were inserted 2 steel pins to 
hold the isolated muscle, and 2 silver stimulating electrodes 
(0.88 mm diameter fashioned out of jewellery-grade silver 
(Dansk Hollandsk Ædelmetal A/S, Copenhagen, Denmark). 
The stimulator used was a DS3 Isolated Stimulator 
(Digitimer Ltd.) linked to an 8S MacLab A/D Converter 
(AD-Instruments, UK). Twitch and tetanic contractions 
were measured using a FTO3 force displacement transducer 
(Grass Instrument, West Warwick, RI) connected to a home-
built bridge amplifier and interfaced with a 8S MacLab A/D 
Converter (ADInstruments, Chalgrove, Oxfordshire, UK).
 
Incubation solutions. Isometric force was measured 
under the following conditions: normal Ringer (Ringer), 
Human Uremic Ringer (HU) and Human Uremic Ringer 
with AKG replacing glucose (HUA). Another series of similar 
experiments were performed using the HU Ringer, but with 
succinate as the key metabolic compound rather than AKG, 
denoted as HUS. The composition of the various Ringers 
used is shown in Table 1. The HU Ringer was based on typical 
haemodialysis patient values [1]. Suspended isolated muscles 
were placed into the thermostatically-controlled chambers 
at 38°C, filled with one of the above Ringer solutions and 
continuously oxygenated with a mixture of 95% O2 and 5% 
CO2 (pH 7.4). All Ringers were adjusted to approximately the 
same osmolarity. 
Force measurements. The muscles were suspended 
vertically in a force-displacement FT03 Grass Force transducer 
(Grass Instruments, Quincy, MA) setup. The recorded signal 
was adjusted to zero for muscle slack with the aid of an offset 
dial mounted on the pre-amplifier unit. Each muscle was 
exposed to 5 single stimulations where the length of the 
muscle was adjusted to a length that gave the maximal twitch 
tension (duration 2 ms, 2 Hz, maximal voltage 90 V, current 
32 mA) with the aid of a PowerLab /8S A/D converter (AD-
Instruments, Chalgrove, Oxfordshire, UK). The transducer 
scale was set at 200 mV, and a recording speed of 1,000 data 
samples per second was used. Muscles were left in either 
normal Ringer or a uremic Ringer, to equilibrate for 30 
minutes. Following the equilibration period, the muscle was 
stimulated continuously to fatigue. 
In each experiment, EDL muscles from contra-lateral 
legs were measured simultaneously in normal Ringer and 
in a uremic Ringer in order to carry out a valid comparison 
between the control and uremic environments. In order to 
facilitate comparison of muscles from different rats, the 
relative decline in force was calculated as a percentage of the 
maximum isometric force – reached approx. 1 sec after the 
onset of stimulation, as described previously [9]. 
Statistical analysis. Data are presented as means ± 
SE. Differences between means were tested for statistical 
significance with the use of a student’s paired t-test, with an 
additional test for Gaussian Normal Distribution using the 
Kolmogorov-Smirnov KS distance. Data were found to be 
normally distributed and to have equal variance. Differences 
showing a P value >0.05 were considered non-significant. 
RESULTS
In a previous study involving the slow-twitch soleus muscle 
of the rat, the rate of decline in force during a period of 
sustained field stimulation was not significantly different for 
muscles incubated in a uremic solution cf. those incubated 
in Ringer [1]. 
Force measurements. In the current study, the isometric 
force for a continuously stimulated EDL muscle under normal 
and uremic conditions are shown in Figures 1 and 2. EDL 
muscles, which are fast-twitch, showed a significantly faster 
rate of fatigue as a result of field stimulation when incubated 
in the human uremic (HU) Ringer cf. those incubated in 
normal Ringer. The rate of decline in force measured over the 
first 8 seconds after maximum force production was 8.0%/sec 
Table	1 Comparison of chemical composition of incubation buffers 
used in connection with isolated EDL muscles of adult rats. HU – 
human uremic conditions; HUA – HU buffer where glucose has been 
exchanged for alpha-ketoglutarate (AKG); HUS – HU buffer where 
glucose has been exchanged for succinate. Values are presented 
as mmol/l 
 Ringer HU HUA HUS
Na+ 145 140 134.8 134.8
HCO3
- 25 19 14 14
Ca2+ 1.27 1 1 1
Cl- 127 109.5 109.5 109.5
Mg2+ 1.2 0.75 0.75 0.75
PO4
3- 1.2 4 4 4
K+ 5.9 3.6 3.6 3.6
Urea - 30 30 30
Glucose 5 5 - -
AKG - - 5 -
Succinate - - - 5
SO4
2- 1.2 0.75 0.75 0.75
Mosmol/l 313 303 303 303
Na+ / K+ ratio 24.5 : 1 38.8 : 1 37.4 : 1 37.4 : 1
Na+ / Cl- ratio 1.14 : 1 1.27: 1 1.23 : 1 1.23 : 1
Final pH 7.4 7.4 7.4 7.4
Incubation buffers were prepared using the following fine 
chemicals supplied by Merck: NaHCO3, CaCl2, MgSO4, KH2PO4, 
Na2HPO4, NaCl, KCl, H2NCONH2, D-Glucose; the latter 2 two 
chemicals were added last. pH was adjusted by the addition of HCl 
or NaOH where necessary; however, we found that the buffers had 
a final pH very close to 7.4. Buffers did not fall out of solution; pH 
was checked routinely at the start and finish of each experiment.
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for muscles incubated in Ringer, a value that was significantly 
different from those values measured for muscles incubated 
in the HU solution: 9.8 %/sec, (22% faster P<0.01).  
The substitution of AKG for glucose in the HU Ringer, 
producing the Ringer denoted as HUA, resulted in an 
improved fatigue profile for stimulated EDL muscles. Indeed, 
the improvement in the fatigue pattern for muscles incubated 
in HUA, as opposed to the HU Ringer, meant that these 
muscles were not found to be significantly different from 
those muscles incubated in normal Ringer. Substitution of 
succinate for glucose in the HU Ringer, producing the Ringer 
denoted as HUS, also resulted in an improved fatigue profile 
for stimulated EDL muscles. As with muscles incubated in 
HUA, the rate of decline in force measured over the first 
8 seconds after maximum force production was 8.8 %/sec, a 
value that did not differ significantly from that of muscles 
incubated in Ringer. However, unlike the HUA Ringer, EDL 
muscles incubated in HUS were initially significantly weaker 
in terms of percentage of maximal isometric force for the first 
4 seconds of force production, compared with those muscles 
incubated in Ringer. After 2 seconds of force production, 
muscles incubated in HUS were 7.5 % weaker, and after 
4 seconds they were 15.5 % weaker than muscles incubated 
in Ringer (both P<0.05); thereafter there was no significant 
difference between the HUS and Ringer muscles. 
EDL muscles measured in the current study produced an 
isometric force of 0.90 ± 0.06 N, which is very comparable 
with previously published values [1].
DISCUSSION
The results of this study not only confirm previous work 
showing that the effect of a uremic environment on fast-twitch 
skeletal muscle is an impaired contractile performance, but 
also show that such effects can be alleviated to a great extent 
by the addition of the TCA intermediates alpha-ketoglutarate 
or succinate. 
Uremic patients – apart from renal failure – have a serious 
problem with muscle fatigue which diminishes their quality of 
life. If this fatigue could be treated, or even partly treated, the 
patients’ lives would therefore improve significantly. However, 
at present, loss of fast muscle function remains symptomatic of 
these patients, with some studies showing atrophy of the type 
II fibres, and unpreventable loss of fine-motor skills.
In the present study, we have examined normal rat muscles 
exposed to uremic conditions. In this situation, the muscles 
have not had time to develop long-term effects of uremia; 
rather, we have measured the immediate consequences for 
muscle performance of exposure to the uremic environment. 
The osmolality in these in vitro experiments was deliberately 
kept constant as a hypertonic environment is known to 
diminish twitch tension alone [11], and although this must 
play a role in vivo, the present study has attempted to focus 
on other underlying effects. 
Human studies provide clear scientific evidence that the 
intramuscular concentration of Pi increases linearly with 
an increase in plasma Pi concentration, since the plasma 
membranes of skeletal myocytes are sufficiently permeable to Pi 
to allow detectable bulk movement of Pi across the membrane 
within a time-scale of minutes [12]. The precise effect of 
increased Pi on intact muscle-cell function has been difficult to 
prove without also affecting other metabolic changes. However, 
with the use of a genetically modified mouse (CK-/-), it is now 
possible to address this very issue [4]. Westerblad and colleagues 
(2002), have shown that fast-twitch skeletal muscles from such 
(CK-/-) mice display an increased myoplasmic Pi concentration 
at rest, and show a markedly lower force than that of wild-type 
mice. Additional support for a coupling between myoplasmic 
Pi concentration and force production in intact muscle cells 
comes from experiments in which reduced myoplasmic Pi has 
been associated with increased force production [13]. The exact 
mechanism of Pi on force production remains to be explained, 
but it may be speculated that the increased myoplasmic Pi may 
decrease force production by direct action on cross-bridge 
function; alternatively, increased Pi may inhibit the ATP-
Figure	1 The relation between percentage maximal isometric force vs. time for 
stimulated extensor digitorum longus (EDL) muscles of rats incubated in normal 
Krebs Ringer ( ) or, either a human uremic (HU) solution ( ) or a human uremic 
+ alpha-ketoglutarate (HUA) solution ( ), respectively. For details of bathing 
solutions used, see Table 1. Isolated muscles were continuously stimulated at 
90 Hz for a period of 16 s, with 32-mA pulses of 1 ms duration; this represents 
supramaximal, constant-current field stimulation. Force recordings made on a 
force transducer attached to an A/D converter, sampling rate 1,000 samples/s. Each 
point represents mean ± SE. Significant differences between muscles incubated 
in uremic solutions and muscles incubated in normal Krebs Ringer: a = p<0.05 
and b = p<0.01.
Figure	2 The relationship between percentage maximal isometric force vs. time 
for stimulated extensor digitorum longus (EDL) muscles of rats incubated in normal 
Krebs Ringer ( ) or, either a human uremic (HU) solution ( ) or a human uremic 
+ succinate (HUS) solution ( ), respectively. For details of bathing solutions used, 
see Table 1. Isolated muscles were continuously stimulated at 90 Hz for a period of 
16 s, with 32-mA pulses of 1 ms duration; this represents supramaximal, constant-
current field stimulation. Force recordings made on a force transducer attached to 
an A/D converter at sampling rate of 1,000 samples/s. Each point represents mean 
± SE. Significant differences between muscles incubated in uremic solutions and 
muscles incubated in normal Krebs Ringer: a = p<0.05 and b = p<0.01.
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driven sarcoplasmic Ca2+ uptake, so that less Ca2+ would be 
available for release, leading to a decline in force [14]. 
Whatever the mode of action of phosphate, keto-acid 
supplements, which are: 1) phosphate free, and so help to 
reduce phosphate intake, and 2) are often provided with 
calcium salts which promote phosphate binding in the 
intestine, thereby increasing phosphate excretion, and have 
been shown to reduce the progression of renal insufficiency 
in chronic renal failure [15,16]. 
While the current results show that both the TCA cycle 
intermediates investigated have a beneficial effect on muscle 
performance for muscles exposed to a uremic condition in 
vitro, the precise means of action still needs to be determined. 
However, the short time-frame adopted in this study means 
that any TCA effects on transcription/translation within the 
isolated muscles can effectively be ignored. It was reported 
recently that a decrease in inorganic phosphorus levels occurred 
in rats after 7 days of treatment with AKG (p.o.) [17]. We 
therefore suggest that the data of Mudge [8], which provides 
clear evidence of a significant increase in cellular metabolism 
after exposure to both AKG and succinate, combined with 
the results of Bhattacharya and co-workers [17], and the 
observations of the effects of a high level of Pi on muscle 
performance [4, 13], lend considerable weight to the role of 
elevated plasma and cellular Pi in the muscle weakness seen 
with exposure to a uremic environment, and the alleviating role 
of TCA cycle intermediates. Furthermore, we hypothesise that 
the addition of TCA cycle intermediates to muscle incubated in 
a uremic environment results in incorporation of Pi into high 
energy bonds as the succinyl CoA is converted to succinate. In 
the present study, it appears that AKG is slightly more efficient 
than succinate in alleviating or restoring the effects imposed 
on muscle performance by exposure to a uremic environment 
in vitro. In an in vivo situation, however, one might anticipate 
an even greater beneficial affect of AKG cf. succinate, since it 
is known that AKG can and does complex with ammonia in 
muscle to form glutamine. In so doing, AKG would not only 
spare the organism the ‘cost’ of 3 molecules of ATP with the 
release of 3 x Pi as part of urea synthesis, it would additionally 
provide the release of glutamine which acts as an obligatory 
substrate for the kidney in ammonia production. 
Clearly, this study shows that AKG, and for that matter 
succinate as well, have an effect on the fast muscles exposed 
to uremic conditions. Therefore, a supplementary intake, 
perhaps in the form of AKG tablets, could be a possible means 
of improving the fast muscle function affected by the uremic 
condition. Indeed, in terms of dosage it has been ascertained 
that AKG can be administered in doses of 2.0 g kg-1 (per os) 
without any change in haematology, biochemistry, or histology 
of the vital organs in rats [17]. However, administering AKG 
orally is a simple matter in the case of healthy individuals, but 
to uremic patients this could be a problem. Perhaps a means of 
overcoming this problem may be found in the dialysis solutions 
used for the treatment of these patients, or the use of succinate 
rather than AKG.
CONCLUSION
The results of this study indicate that the internal 
environment bathing nerve and muscle cells plays an 
important role in the occurrence of the muscle weakness 
and fatigue, which is symptomatic of chronic renal failure. 
The measurements of muscle fatigue during normal and 
uremic conditions clearly show that a uremic environment, 
in itself, will rapidly induce muscle weakness, and that this 
weakness can be alleviated to a great extent by the presence 
of the TCA intermediates alpha-ketoglutarate or succinate. 
Further studies are necessary to elucidate the precise means 
by which these protective/restorative effects are achieved, and 
the potential for such treatment in a clinical situation.
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